PACB, Pacific Biosciences of California

Held by 0 tracked investors, USD 0 in total, as of 2020 Q3. Source: quarterly 13F filings via dataroma.com.

Holders, 2020 Q3

Prem Watsa: USD 550,400, 0.0% of their portfolio, sold

PACB

Pacific Biosciences of California

$0Kvalue −100%

held by 0 investors · 2020 Q3

0 buying1 selling

Percentages are the change in shares held, not a return.

2018 Q4: Prem Watsa 160,000 shares; share price USD 7.39
2019 Q1: Prem Watsa 160,000 shares; share price USD 7.23
2019 Q2: Prem Watsa 160,000 shares; share price USD 6.04
2019 Q3: Prem Watsa 160,000 shares; share price USD 5.15
2019 Q4: Prem Watsa 160,000 shares; share price USD 5.14
2020 Q1: Prem Watsa 160,000 shares; share price USD 3.06
2020 Q2: Prem Watsa 160,000 shares; share price USD 3.44
2020 Q3:

shares held · price0 shares · 2020 Q3

$3.44

2018 · peak 160K sharesprice up to $7.39 · 2020

GigaInvestors GigaValueNewsletter Agent API Contact